Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Insulin vs Autologous Serum for Corneal Healing After PRK
NCT05331859Phase 1Unknown
- Sponsor
- Benha University
- Start
- May 2022
- Primary completion
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label trial of Generex Oral-lyn in corneal epithelial defect, sponsored by Benha University. Status: unknown.
02
Drugs
Generex Oral-lyn
03
Conditions
corneal epithelial defect
Beyond the preview
Go deeper on NCT05331859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05331859.